Skip to content
    BROWSE CERTIFIED COMPANIES
    Adaptimmune

    Adaptimmune

    Updated December 2023.
    85%
    Employees say this is a great place to work*

    About Adaptimmune

    Company Overview
    Adaptimmune is a leader in TCR T-cell therapy, focused on designing and delivering novel cancer immunotherapy products. We utilize the body’s own machinery – the T-cell – to target and destroy cancer cells. We believe our therapies have the potential to significantly impact cancer treatment and clinical outcomes of people with cancer.
    Company Size 224 UK-based Employees
    (Large)
    INDUSTRY Other
    CONNECT
    Adaptimmune Head Office
    United Kingdom

    Employee Demographics

    Tenure
    • <2 years - 25%
    • 2-5 years - 62%
    • 6-10 years - 11%
    • 11-15 years - 1%
    • 16-20 years - 1%

    Company Culture at Adaptimmune

    The employee experience below at Adaptimmune, compared to a typical company.

    85% of employees at Adaptimmune say it is a great place to work*, compared to 54% of employees at a typical UK based company.
    Adaptimmune
    85%
    Typical Company
    54%
    *Responses to the statement “Taking everything into account, I would say this is a great place to work.” Source: Great Place To Work® 2021 Global Employee Engagement Study.

    99%

    This is a physically safe place to work.

    98%

    People here are treated fairly regardless of their sexual orientation.

    96%

    When you join the company, you are made to feel welcome.

    94%

    People here are treated fairly regardless of their gender.

    93%

    Our facilities contribute to a good working environment.

    Working at Adaptimmune

    Working at Adaptimmune

    Best Workplaces Lists

    Great Place To Work® is proud to recognise Adaptimmune on the following Best Workplaces Lists.

    Don't See Your Company Listed?

    Your organisation can be a Certified™ great workplace in as little as 2 weeks. Start your Certification™ journey today!

    Get Certified
    Worlds_Best_Workplaces_LP_Hero(1)